发布于: 公告转发:0回复:0喜欢:0
$Immune制药(IMNP)$ 8-K - Current report Filed: 2019-02-14 AccNo: 0001144204-19-008109 Size: 44 KBItem 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet ArrangementItem 9.01: Financial Statements and Exhibits 网页链接